Showing 1,801 - 1,820 results of 104,844 for search '(( 2 fold decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.48s Refine Results
  1. 1801

    Effect of OKN-007 on the immunoexpression of SULF2 in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

    Published 2015
    “…OKN-007 (NR); (4) Normal vs. OKN-007 (R); (5) UT vs. OKN-007 (NR); and (6) Normal vs. OKN-007 (NR).…”
  2. 1802

    Effect of OKN-007 on the immunoexpression of PDGFR-α in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

    Published 2015
    “…OKN-007 (NR); (4) Normal vs. OKN-007 (R); (5) UT vs. OKN-007 (NR); and (6) Normal vs. OKN-007 (NR).…”
  3. 1803
  4. 1804
  5. 1805
  6. 1806
  7. 1807
  8. 1808
  9. 1809

    Response of small airway tissues infected with EV-D94 and decreasing doses of EV-D68. by Ines Cordeiro Filipe (5849144)

    Published 2022
    “…<p>Tissues were infected with 1E7 RNA copies of EV-D94 (equivalent to 2,46E4 TCID50) and 1E7 RNA copies of EV-D68 (3,3E5 TCID50) as well as decreasing doses of the latter. …”
  10. 1810
  11. 1811
  12. 1812

    Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

    Published 2019
    “…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
  13. 1813
  14. 1814

    Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

    Published 2020
    “…<p>(A) A375 melanoma cells were treated with 0.5 μM, 1.0 μM, or 2.0 μM 5-, 10-, or 16-TPP for 1 h and analyzed for mitochondria membrane potential by the JC-1 method (* significant relative to control; p<0.05; n = 2 from 2 separate experiments; N = 4). …”
  15. 1815
  16. 1816
  17. 1817

    S5 Raw image - by Zhi Xuan Low (19270163)

    Published 2024
    “…This study also revealed a notable sequential reduction in serum levels of tumour markers, including carcinoembryonic antigen (CEA) and mouse Cytochrome P450 1A2 (CYP1A2), correlating with a significant decrease in tumour bulk volume upon treatment commencement. …”
  18. 1818
  19. 1819
  20. 1820